Osiris Therapeutics, Inc. (OSIR) Stock

Business Intelligence
Transcripts
Events
Key Developments

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

149 people get OSIR articles and Market Currents by email alert.

Get email alerts on OSIR »

OSIR Market Currents more »

May 18 Premarket gainers: WGO +21%. FFN +14%. QPSA +11%. OSIR +10%. FL +8%. CRM +7%. NBG +6%. YHOO +5%.
Losers: ADSK -9%. GSS -8%.
Comment!
[On the Move]

OSIR in Focus more »

Osiris Therapeutics, A Short-Seller's Dream

Shortzilla • Fri, Mar 30 • 6 Comments
Osiris Shows No Reason To Invest In Stem Cell Ideas

Derek Lowe • Thu, Jan 5 • 14 Comments
Sirus XM: Year In Review And 2012 Outlook

Pragmatic Bear • Wed, Dec 28, 2011 • Comment!
Osiris: Finding Opportunity Amongst Uncertainty

TheMarketFinancial • Sun, Jan 30, 2011 • 1 Comment
Osiris Therapeutics, Inc. Q1 2010 Earnings Call Transcript

Fri, May 7, 2010 • Comment!

OSIR Related Articles more »

Weighing The Benefits Of Osiris' First Cell Therapy Approval

A John Hodge • Wed, May 23 • 4 Comments
Stem Cell Hype Has Yet To Breed Profits

Apsara Biotechnology Research • Tue, May 22 • 37 Comments
Brief Review Of A Few Biotechs

Mina Shaker • Mon, May 21 • 19 Comments
Stem Cell Biotechs Report 2011 Year In Review: Part II

Chemistfrog • Mon, May 7 • 1 Comment
BioTime Is Running Out Of Time - Short-Sell Idea

Martin Shkreli • Wed, Apr 11 • 20 Comments
Behavioral Finance Lessons From Magic Formula Investors

Value Research • Sun, Feb 26 • 9 Comments
5 Risky Biotech Stocks To Avoid, 2 To Consider

Dividend Kings • Wed, Jan 18 • 9 Comments
Regenerative Medicine Universe Earnings Report Card Q3/11

Henry McCusker • Fri, Nov 11, 2011 • Comment!
Post Excessive Sell-Off, September Is Still In The Wind

Henry McCusker • Tue, Aug 30, 2011 • Comment!
Regenerative Medicine Companies Trading At Huge Discounts

Henry McCusker • Wed, Aug 24, 2011 • 3 Comments

OSIR News more »

Stocks to Watch: Stocks to watch Friday: Osiris, Autodesk, Marvell

at MarketWatch.com (May 18, 2012)
Biotech Report: Are stem-cell stocks a good buy?

at MarketWatch.com (Jul 13, 2011)
Stem-cell stocks rise on artificial-trachea report

at MarketWatch.com (Jul 8, 2011)
Health-care Stocks: Radiation drug makers lose some ground

at MarketWatch.com (Mar 16, 2011)
Stem-cell stocks regain ground

at MarketWatch.com (Aug 26, 2010)

OSIR Press Releases and Filings more »

World's First Approved Stem Cell Drug; Osiris Receives Marketing Clearance from Health Canada for Prochymal

Business Wire (May 17, 2012)
Osiris Therapeutics Reports First Quarter 2012 Financial Results

Business Wire (May 11, 2012)
Osiris Therapeutics Announces First Quarter 2012 Financial Results Conference Call

Business Wire (May 3, 2012)
Osiris Therapeutics Provides Update on Groundbreaking Stem Cell Trial for Type 1 Diabetes

Business Wire (Jan 3, 2012)

OSIR Latest Transcript more »

Osiris Therapeutics, Inc. Q1 2010 Earnings Call Transcript

Fri, May 7, 2010
Popular searches: osiris, crohn, acute, biosurgery, call, important, program, sap, thank, trial.

Earlier OSIR transcripts

OSIR Cramer more »

Currently, there are no Cramer articles on OSIR.

OSIR Instablog posts more »

Magic Formula Investing Weekly Roundup 1/22/2012

Sun, Jan 22 • MagicDiligence • Comment!
Magic Formula Investing Weekly Roundup 11/13/2011

Sun, Nov 13, 2011 • MagicDiligence • Comment!
10K filing by OSIR shows it can help Japan with Radiation exposure treatment.

Wed, Mar 16, 2011 • EPS100Momentum • 2 Comments
XRIT, MRX, OSIR, NHPR, BRCD, SNTA - DrStockPick.com Watch List for Monday Feb. 28, 2011

Sun, Feb 27, 2011 • HotDrStockNews • Comment!
New Biotech Milestones and Database Updates for July 26, 2010

Mon, Jul 26, 2010 • Andrew Nava • Comment!

Write a post on OSIR

OSIR StockTalks

OSIR vs. ETF Alternatives

Company Description

We are a leading stem cell therapeutic company headquartered in Columbia, Maryland and focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. We were incorporated in Delaware in April 2002. Our predecessor company was... More

Sector: Healthcare

Industry: Biotechnology

Country: United States